China-based Sino Medical Sciences Technology Inc. (SHA: 688108) has announced receiving marketing approval from Peru’s Dirección General de Medicamentos, Insumos y Drogas (DIGEMID) for its SC HONKYTONK coronary balloon dilation catheter. This marks another milestone in the global expansion of the company’s product portfolio, further solidifying its presence in international markets.
Product Overview and Applications
The SC HONKYTONK coronary balloon dilation catheter is designed to address narrowed segments or bridging sites of coronary arteries, improving myocardial perfusion. The device has already secured registrations in multiple regions, including mainland China, the US, Thailand, Taiwan, India, Russia, and Hong Kong. Its widespread adoption underscores its clinical utility and safety profile in treating cardiovascular conditions.
Global Market Expansion
With the latest approval from Peru’s DIGEMID, Sino Medical Sciences continues to expand its global footprint. The company’s efforts to penetrate international markets highlight its commitment to providing innovative and effective medical devices to address unmet needs in cardiovascular care. The SC HONKYTONK catheter’s growing list of approvals positions it as a reliable option for healthcare providers worldwide.-Fineline Info & Tech
Leave a Reply